Pisit Pitukcheewanont, MD
Pisit Pitukcheewanont, MD, also known as Dr. Duke, is a professor of Clinical Pediatrics and Clinical Director of the Pediatric Bone Program at Center of Endocrinology, Diabetes and Metabolism at Children’s Hospital Los Angeles and the Keck School of Medicine of the University of Southern California. He earned his MD degree and interned at Chiang Mai University, Chiang Mai, Thailand.
He did his residencies in pediatrics at Chiang Mai University and at Le Bonheur Children’s Medical Center of the University of Tennessee in Memphis where he finished his pediatric endocrine fellowship as well.
He has over 50 publications in peer-reviewed, non-peer-reviewed, book chapters. His recent publications have been concerned with the disparities resulting from the various methods of measuring bone density and pediatric bone disorders.
Bone health children
common metabolic bone disorders such as rickets, osteogenesis imperfecta , hypoparathyroidism
rare metabolic bone disorders such as hypophosphatasia, osteopetrosis
abnormal calcium and Phosphate metabolism
abnormal Vitamin D and Parathyroid disorders
childhood osteoporosis
genetic and acquired bone disorders : paget's disease
low bone density associated with chronic diseases
multiple fractures with no known etiology
patients with family history of metabolic bone disease
growth with bone disorders
low bone density for age
multiple fractures without significant trauma
Education
Chiang Mai University
Chiang Mai University: Pediatrics
Chiang Mai University: Pediatrics
University of Tennessee/Memphis: Pediatrics
University of Tennessee, Medical Center of Knoxville: Pediatric/Endo/Metabolism
Accomplishments
Pediatric Endocrinology: American Board of Pediatrics
Pediatrics: American Board of Pediatrics
The Lawson Wilkins Pediatric Endocrine Society
The American Society for Bone and Mineral Research
Society of Pediatric Research
“Best Doctors of America” since 2003,
“America’s Top Pediatricians” since 2007,
“ Los Angles Super Doctors” since 2007 ,
“Southern California Super Doctor” since 2007
“Madison Who is Who in America” since 2007.
" Thai American Physicians Foundation (TAPF) Medical Research Award" in 2008
" Thai-American Visiting Professor Award" in 2008
" Top Doctors Los Angeles" since 2010
" Top Doctors Pasadena Magazine" since 2010
" Madison’s Who’s Who in Medicine" since 2011
Bone health and bone metabolism
Publications
Research
Fracture, Bone density, Bone mass, Bone health, Growth, Growth disorder, Hypercalcemia, Metabolic bone disorder
CURRENT FUNDING
Ultragenyx Pharmaceuticals, Alexion Pharmaceuticals, NPS Phramaceuticals
CURRENT RESEARCH STUDIES
1. A phase 2 open-label trial to assess the efficacy and safety of KRN23, an antibody to FGF23, in subjects with tumor-induced osteomalacia or epidermal nevus syndrome -associated osteomalacia
2. A Retrospective Longitudinal Study of Skeletal Outcomes in Children with X-linked Hypophosphatemia
3. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of KRN23 in Adults with X-linked Hypophosphatemia
4. Physicians Advancing Disease Knowledge in Hypoparathyroidism: A Natural Registry for Patients with Chronic Hypoparathyroidism
5. Retrospective Hypophosphatasia EMR Analysis
6. RANK Ligand Assay in Patients with Metabolic Bone Disease
7. An Open-Label, Phase 2 Study to Assess the Safety, Pharmacodynamics, and Efficacy of KRN23 in Children from 1 to 4 Years Old with X-linked Hypophosphatemia
8. A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients with X-linked Hypophosphatemia